C12N 2795/10322
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2795/10322 (New viral proteins or individual genes, new structural or functional aspects of) appears on 87 US grants and 105 published applications in this corpus.
Search patents in C12N- Granted patents
- 87
- Published applications
- 105
- Assignees
- 78
- Inventors
- 226
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 2 |
| 2002 | 3 | 2 |
| 2003 | 0 | 3 |
| 2004 | 1 | 1 |
| 2005 | 1 | 2 |
| 2006 | 0 | 3 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 2 |
| 2012 | 1 | 4 |
| 2013 | 2 | 4 |
| 2014 | 2 | 2 |
| 2015 | 2 | 2 |
| 2016 | 0 | 4 |
| 2017 | 3 | 4 |
| 2018 | 5 | 2 |
| 2019 | 2 | 4 |
| 2020 | 4 | 8 |
| 2021 | 3 | 8 |
| 2022 | 8 | 14 |
| 2023 | 10 | 7 |
| 2024 | 4 | 10 |
| 2025 | 5 | 8 |
| 2026 | 0 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population4 Nov 2025US 12,460,216 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages encoding a human protein28 Oct 2025US 12,454,696 B2Eligo Bioscience
- Lentiviral-based vectors and related systems and methods for eukaryotic gene editing26 Aug 2025US 12,398,182 B2Wake Forest University Health Sciences
- Compositions and methods for inhibiting the proliferation of enterotoxigenic Bacteroides fragilis22 Apr 2025US 12,280,081 B2Intron Biotechnology, Inc.
- Method of treating pathogenic bacterial infectious diseases11 Feb 2025US 12,220,448 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Enzymes capable of mediating large-fragment dna integration into mammalian genomes and uses thereof27 Aug 2026US 2026/0250718 A1Yoltech Therapeutics Co., Ltd
- Cutibacterium acnes recombinant phages, method of production and uses thereof6 Aug 2026US 2026/0226484 A1Eligo Bioscience
- Compositions and methods for adeno-associated viral production7 May 2026US 2026/0125702 A1Asimov Inc.
- Phage-derived particles for in situ delivery of dna payload into c. acnes population23 Apr 2026US 2026/0109991 A1Eligo Bioscience
- Delivery of heterologous proteins26 Feb 2026US 2026/0055146 A1Sana Biotechnology, Inc.
Most cited
By later US patents
- Generation and selection of novel DNA-binding proteins and polypeptides293US 5,096,815 AProtein Engineering Corporation · 1992
- Generation and selection of novel DNA-binding proteins and polypeptides254US 5,198,346 AProtein Engineering Corporation · 1993
- Phagemid for antibody screening59US 5,849,500 ADeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts · 1998
- D29 shuttle phasmids and uses thereof50US 5,773,267 AAlbert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University · 1998
- Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system48US 5,688,501 AExponential Biotherapies, Inc. · 1997